Docoh
Loading...

BLUE Bluebird bio

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

ESG term mentions

In last year of SEC filings
CleanClimateContaminantEcologicalEcosystemEnvironmentEnvironmentalEscapeHazardIntensityMaterialsNatureOffsetPackagePackagingPandemicRaw MaterialsRegenerativeResiliencyToxicWasteWindAccessAfrican AmericanBenefitsBlackCalifornia Consumer Privacy ActCharitableCollective BargainingCommunityCultureCustomerCyberCyber SecurityData PrivacyData SecurityDeathDisabilityDiversityDiversity and InclusionDrug PricingEmployeeEmployee EngagementEmployee Resource GroupEmployee RetentionEngagementEthnicGenderGeneral Data Protection RegulationHealth CareHealthcareHireHiringHuman CapitalHuman ResourcesIncidentIndigenousInequalityInjuredInjuryParental LeavePay EquityPay for PerformancePerquisitesPrivacyRecallRecruitRecruitmentReimbursementRetentionRetirementSafetySatisfactionSkillSkilledSkillsSocialSocietyStakeholderSupplierSupply ChainTalentTrainingUnionVolunteerWomenWorkersWorkforceAnti-corruptionAntitrustAssessmentAssuranceAttorney GeneralAttorneys GeneralAuditBonusBribeBriberyChronicClass Action LawsuitClassifiedClassified BoardClawbackCommitmentConflict of InterestCorporate GovernanceCorruptionDepartment ofEnterprise Risk ManagementEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentInequalityInnovationInnovativeInvestigationLawsuitLeadershipLitigationLong-termMajorityMissionOverseeOversightPerquisitePlaintiffPledgingProcurementPurposeR&DReputationReputationalReputational RiskResearch and DevelopmentResponsibilityResponsibleSelf-evaluationSpecial MeetingStockholder EngagementStockholder OutreachStrategySupermajoritySustainabilitySustainableTargetsTaxTenureTransparencyTransparentVoting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM



On June 15, 2021, bluebird bio, Inc. (the “Company”) held its previously announced Annual Meeting of Stockholders (the “Meeting”), at which a quorum was present. At the Meeting, the stockholders of the Company voted on the proposals as follows: (i) John O. Agwunobi, M.D., Daniel S. Lynch, and William R. Sellers, M.D. as Class II members of the Board to serve until the Company’s 2024 annual meeting of stockholders (“Proposal 1”); (ii) to approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers (“Proposal 2”); (iii) the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers ("Proposal 3"); (iv) to approve an amendment to the Company's 2013 Employee Stock Purchase Plan ("Proposal 4"), and (v) ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021 (“Proposal 5”).




The Company’s stockholders re-elected the three persons listed below as Class II directors pursuant to Proposal 1. The voting results were as follows:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
John O. Agwunobi, M.D.30,724,36610,266,016117,5568,990,117
Daniel S. Lynch39,876,6501,109,554121,7348,990,117
William R. Sellers, M.D.40,679,679306,213122,0468,990,117





The Company’s stockholders approved Proposal 2 in a non-binding advisory vote. The voting results were as follows:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
38,890,7001,971,886245,3528,990,117


The Company’s stockholders voted once every year for Proposal 3. The voting results were as follows:

1 Year2 Years3 YearsAbstentions
40,627,097146,506274,17160,164





The Company’s stockholders approved Proposal 4. The voting results were as follows:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
40,467,196557,45783,2858,990,117





The Company’s stockholders approved Proposal 5. The voting results were as follows:




Votes ForVotes AgainstAbstentionsBroker Non-Votes
49,526,131453,658118,2660